CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Board Of Directors

Joseph Dowling

Chief Executive Officer

Mr. Dowling was appointed as Chief Executive Officer of the Company in May 2018. Prior to his appointment as CEO, Mr. Dowling held the position of CFO with the Company since 2014. Prior to 2014, Mr. Dowling held numerous senior positions including President and Chief Financial Officer of MediVas, LLC, a biotechnology company focused on drug formulation and delivery from 2005 to 2013 where he led day-to-day operations, drug research and development, product development and commercialization and strategic alliance building including license agreements with Pfizer, Merck, Wyeth, DSM, Guidant and Boston Scientific. Mr. Dowling also served as a Managing Director at Citigroup, a global financial services firm, and earlier in his career served various operating, finance and accounting roles in both public accounting and in the banking industry. Mr. Dowling graduated from University of California, Los Angeles in Economics and is a certified public accountant.

Joerg Grasser

Chief Financial Officer
Mr. Grasser has more than 20 years of experience and an extensive background in accounting, finance, financial reporting and operations. Prior to his role at CV Sciences, Mr. Grasser was Controller at Ballast Point Brewing, a subsidiary of Constellation Brands, Inc. from 2015 to 2018. Prior to his role at Ballast Point, Mr. Grasser held senior finance positions with Sequenom, Inc. from 2014 to 2015 and Peregrine Semiconductor Corporation from 2010 to 2014. Mr. Grasser began his career at KPMG LLP providing audit and IT advisory services, advancing to senior audit manager. Mr. Grasser has an MBA from the Keller Graduate School of Management, a BA from University of Regensburg and is a Certified Public Accountant.

Michael J. Mona, III

Chief Operating Officer

Mr. Mona III cofounded CV Sciences and has been instrumental in developing the worldwide supply chain for hemp products. Mr. Mona’s expertise in hemp farming, processing, testing and product development has directly led to the Company’s successful consumer products division. Mr. Mona III graduated from the University of San Diego in Business Administration.

Dr. Douglas Mackay, N.D.

Senior Vice President of Scientific and Regulatory Affairs
Dr. MacKay serves on the advisory board for the American Botanical Council, the NSF International Joint Committee on Dietary Supplements, and the NIST/NIH Dietary Supplement Laboratory Quality Assurance Program. He is a licensed naturopathic doctor and previously was owner and practitioner in a New Hampshire-based integrative medical practice. Additionally, Dr. MacKay is on the editorial board of three peer-reviewed publications: the official publication of the American Association of Naturopathic Physicians, Natural Medicine Journal, Integrative Medicine—a Clinician’s Journal, and Current Topics in Nutraceutical Research. Dr. MacKay is also Chair of the Steering Committee for the SIDI Work Group.

Dr. MacKay holds a bachelor’s in Marine Biology from the University of California, Santa Cruz and his N.D. from the National College of Natural Medicine in Portland, Oregon.

Gary Sligar

Director of CV Sciences

Mr. Gary R. Sligar served as Managing Principal, President at Trecap Partners, LLC. Mr. Sligar joined Equitable Real Estate in 1986 with responsibility for New York Region asset management operations. Mr. Sligar was the Executive Vice President responsible for the New York office asset management operations for Equitable Real Estate from 1986 to 1989. Mr. Sligar’s career spans 35 years in the commercial real estate industry including appraisal, commercial mortgage, property/asset management, leasing, construction and development. He serves as a Director of the Real Estate Board of New York, Building Owners and Managers Association, and NAIOP. He has served as a Director of CV Sciences, Inc. since June 2, 2016. He received his Bachelor Degree from Tulsa University and completed his graduate study at the University of Houston.

James McNulty

Director of CV Sciences

Mr. James A. McNulty, CPA, has served as a Director of CV Sciences, Inc. since January 1, 2016. He is CEO of MYMD Pharmaceuticals, Inc. (development stage pharmaceutical company), and is Chief Financial Officer for Hopkins Capital Group, an affiliation of limited liability companies which engage in venture activities primarily in development of pharmaceuticals. He serves as Chief Financial Officer of Repurposed Therapeutics, Inc., DBA Defender Pharmaceuticals, Inc. Mr. McNulty was Chief Financial Officer of Biodelivery Sciences International, Inc. (NASDAQ: BDSI) from 2000 until his retirement from BDSI in December 2014.

Joseph Maroon


Joseph Maroon, MD, FACS is a board-certified neurosurgeon and Heindl Scholar in neurosciences. He is regarded as a premier specialist in the surgical treatment of injuries and diseases of the brain and spine, particularly with microscopic and minimally invasive procedures. He has published over 270 papers and is on numerous editorial boards. He is consistently listed in America’s Best Doctors and has an international patient clientele. He is the co-developer of ImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing). Dr. Maroon is also a health and fitness expert and Ironman triathlete. He has written six books including Fish Oil: The Natural Anti-Inflammatory and The Longevity Factor: How Resveratrol and Red Wine Activate Genes for a Longer and Healthier Life. He is president of Inflammation Solutions, LLC, and serves as senior vice-president of the American Academy of Anti-Aging Medicine.